Anton Hoos
Director/Board Member at Patient Focused Medicine Development
Profile
Anton Hoos is currently the Director at Patient Focused Medicine Development since 2014.
He was previously the Vice President at CSL Behring GmbH.
In 2023, he briefly served as the Chief Medical Officer, Head-Medical Affairs, R&D at Swedish Orphan Biovitrum AB.
Dr. Hoos holds an MBA from the University of Toronto and a doctorate from Ludwig-Maximilians-Universität München.
Anton Hoos active positions
| Companies | Position | Start |
|---|---|---|
| Patient Focused Medicine Development | Director/Board Member | 01/01/2014 |
Former positions of Anton Hoos
| Companies | Position | End |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 19/06/2023 |
CSL Behring GmbH
 CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey. | Corporate Officer/Principal | - |
Training of Anton Hoos
| University of Toronto | Masters Business Admin |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Private companies | 2 |
|---|---|
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey. | Health Technology |
| Patient Focused Medicine Development |
- Stock Market
- Insiders
- Anton Hoos